The Bariatric trained medical staff of Dr. Rogers Weight Loss Centers have extensive experience and success utilizing weight loss medications such as weight loss appetite suppressants. Whether you want to lose a lot of weight, or just a little, studies have shown that the integration of weight loss medications into a weight loss program can increase weight loss success.
Dr. Rogers Weight Loss Centers is now prescribing the first new weight loss drugs approved by the FDA in the last 13 years, Qsymia and Belviq.
Qsymia
Qsymia has recently been approved by the FDA for use as an appetite suppressant for weight loss. Qsymia is combination of Phentermine and Topiramate extended-release capsule, and has been studied for chronic weight management.
Belviq
Belviq has been approved for us as an appetite suppressant and for chronic weight maintenance. Belviq has a unique prescribing profile for patients who have had contraindication to previous weight loss prescriptions.
Dr. Rogers Weight Loss Centers is now prescribing Qsymia and Belviq in conjunction with one of our physician supervised weight loss programs.
Each patient’s medical history is individually assessed for the best weight loss medication combination based on an assessment of any current medical problems and expected absorption.
The ability of weight loss appetite suppressant to increase the sensation of fullness and decrease the appetite complements all of the Dr. Rogers Weight Loss Centers programs.
Dr. Rogers Weight Loss Centers:
- Utilizes FDA-approved medications- Phentermine, Qsymia, Bontril, Diethylpropion and Belviq
- Follows American Society of Bariatric Physicians anorectic guidelines
- Employs continuous monitoring for success
